Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases.

The Journal of allergy and clinical immunology - 1 Jan 2022

Crowley T Blaine, Campbell Ian M, Liebling Emily J, Lambert Michele P, Levitt Katz Lorraine E, Heimall Jennifer, Bailey Alice, McGinn Daniel E, McDonald McGinn Donna M, Sullivan Kathleen E

Abstract excerpt

BACKGROUND: Identification of biomarkers associated with immune-mediated diseases in 22q11.2 deletion syndrome is an evolving field. OBJECTIVES: We sought to use a carefully phenotyped cohort to study immune parameters associated with autoimmunity and atopy in 22q11.2 deletion syndrome to define biomarkers associated with immune-mediated disease in this syndrome. METHODS: Chart review validated autoimmune disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to Child, Preschool

Share to DiGeorge Syndrome

Share to Hypersensitivity, Immediate

Share to Infant

Share to Young Adult

Source

Identifiers

PMID: 34144109
DOI: 10.1016/j.jaci.2021.06.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases.PMID 34144109Read ↗

Chromosome 22q11.2 deletion syndrome and DiGeorge syndromeSemantic proximity Read ↗

A Complex Infectious, Inflammatory, and Autoimmune Phenotype Reveals 22q11.2 Deletion Syndrome in an Adult.Semantic proximity Read ↗

The immune deficiency of chromosome 22q11.2 deletion syndromeSemantic proximity Read ↗

Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious PhenotypeSemantic proximity Read ↗

Candidate modifier genes for immune function in 22q11.2 deletion syndrome.Semantic proximity Read ↗

Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic TargetsSemantic proximity Read ↗

Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome)Semantic proximity Read ↗

Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndromeSemantic proximity Read ↗

Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and ManagementSemantic proximity Read ↗

Immunological features of 22q11 deletion syndrome.Semantic proximity Read ↗

Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study.Semantic proximity Read ↗

Immunophenotype identifies children with immune cytopenias at risk of inborn errors of immunity-related mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.